IBL was incorporated on 09th March 1992. In 2018 taken over by Mr. Kasiraman Sayee Sundar new promoter of the Company.
The promoter is aggressive as seen in the latest order book and venturing into new acquisitions.
Business :
The model is to identify and aggregate prospective MSMEs having the potential for high growth.
They aggregate such companies and take them in as a subsidiary of the parent entity, based on mutual agreement.
Single-specialty hospitals, Pharma, homecare services, Agriculture services, Food services, Biotech products, Dairy products, small multi-fuel industrial Boilers, and Green energy plants are some of the high-growth areas where they are looking to aggregate MSMEs.
The subsidiaries in turn enjoy the advantages of access to highly skilled centralized business enablers like legal, secretarial, human resources, and accounting functions.
IBL is venturing into three verticals. 1. Food and Hospitality, 2. Healthcare, 3. Engineering.
The strategy will be mainly an Aggregation of Businesses through mergers, acquisitions, and partnerships.
As the first step, IBL initiated a Scheme of Arrangement (SoA) between IBL with Helios Solution Limited (HSL) and A – Diet Express Hospitality Service Limited (ADEHSL).
HSL is into Power Electronics Products and ADEHSL is into Industrial Catering.adietexpress.com
IBL has partnered with Matrix Boilers Private Limited. They manufacture hybrid boilers and have patented technology in Boiler production. They have installed more than 750 boilers all over India.
IBL to Acquire 51% of Indian Pharmaceutical Company KNISS Laboratories.
Received Contract for Food Supply to Gautam Buddha University in India recently .
Company is operating at ath sales and OPM is healthy .
Recent developments only give me more confidence about this company and promoters.
Technically there is a reversal and a breakout.
MSMEs will be a critical sector for pushing India's growth in the next 5 years and companies like IBL will play a key role in giving them the platform to perform.
Let's hope the orders continue and IBL turns out to be 10 X in the coming years.
#retweet for max outreach .
Ibls wholly owned subsidiary, IBL Healthcare plans to acquire controlling stakes in M/S Peekay Mediequip Limited ("PML"). PML is a company that was under Corporate Insolvency Resolution Process (CIRP). The acquisition process will be completed over a maximum period of 4.5 years.
• • •
Missing some Tweet in this thread? You can try to
force a refresh
How I analyze Indian Microcap & SME stocks using AI
I focus on asking the right prompts across AI tools.
Just use them on your AI like chatgpt , perplexity and thank me later .
1) Microcap Order Book + Execution Reality Check
Prompt:
“You are an Indian microcap analyst. For [COMPANY NAME] (NSE/BSE), build a structured note covering:
Order book: latest value, segment split (EPC/defence/rail/renewables/etc.), client quality, margin profile, retention/LD clauses, advances, execution cycle, and historical conversion to revenue.
Execution: quarterly execution trend, capacity constraints, working capital cycle, procurement dependencies, subcontracting risk, and site-level bottlenecks.
Red flags: aggressive revenue recognition, unusually high other income, sudden debtor jump, related-party transactions.
Output: a table + a 10-bullet ‘investment memo’ with base case / bull case / bear case.”
Prompt:
“Act as a forensic equity researcher. For [COMPANY NAME], perform a management integrity and fraud-risk scan:
Promoter background, past litigations, regulatory actions, auditor changes, resignations (CFO/CS/independent directors), pledging history
Related-party transactions and loan/advance patterns
Cash flow vs PAT divergence (5-year), receivables build-up, inventory anomalies
Auditor notes/qualifications and contingent liabilities
Any signs of round-tripping, channel stuffing, or overstated order book
Give a Risk Score (1–10) and list the top 12 due-diligence questions to ask management.”
Order book & visibility:
Order backlog stands ~₹830 Cr, ensuring strong revenue visibility. Tender pipeline remains robust across segments and geographies, supporting sustained growth. FY26 revenue guidance (~₹700–800 Cr) remains on track.
Capex & expansion: Major capacity expansion underway. Mehru division is ramping up with new production lines – on track to become the largest and most cost-competitive in its segment. A new coil manufacturing plant is slated to go live by June 2026, which will significantly boost future output capacity.
A quiet player in power-quality & grid equipment that’s quietly building scale.
Here’s why it could be India’s next big infra-tech story
A Thread
What they do:
Make high-voltage equipment – coils, transformers, harmonic filters, STATCOM/SVC, capacitor banks – critical for grid stability, renewable integration, and industrial electrification.
Latent View Analytics – FY25 Update
One of India’s pure-play analytics firms just posted a strong FY25.
Revenue up, margins healthy, and new growth levers activated.
Let’s break it down
Numbers (FY25)
Revenue: ₹8,479 Mn (+32.3% YoY)
Net Profit: ₹1,735 Mn (+9.4% YoY)
EBITDA Margin: 23.7%
EPS: ₹8.45
Global Presence
1,600+ employees
Delivery across: US, LATAM, APAC, UK & EU
Models: Onshore / Nearshore / Offshore
Focus expanding in Canada, Mexico, GCC, and SE Asia